Chinese Biotech VC/PE Fundings Rise But Still Modest

 
• By Dexter Jie Yan
  
funding
Private investors eye novel mechanisms and incremental innovation in drug development from China as they commit new investment funds • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from China